 |
|
Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month Outcome
Jae Min Kim, Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee
Korean J Ophthalmol. 2017;31(3):240-248. Published online 2017 Apr 24 DOI: https://doi.org/10.3341/kjo.2016.0026
|
|
Citations to this article as recorded by
 Optical coherence tomography imaging biomarkers associated with neovascular age-related macular degeneration: a systematic review
Rachel L. W. Hanson, Archana Airody, Sobha Sivaprasad, Richard P. Gale
Eye.2023; 37(12): 2438. CrossRef Anti-vascular endothelial growth factor monotherapy or combined with verteporfin photodynamic therapy for retinal angiomatous proliferation: a systematic review with meta-analysis
Matteo Fallico, Iacopo Macchi, Andrea Maugeri, Giuliana Favara, Martina Barchitta, Roberta Magnano San Lio, Antonella Agodi, Andrea Russo, Antonio Longo, Teresio Avitabile, Niccolò Castellino, Michele Reibaldi, Francesco Pignatelli, Maria Vadalà, Clara Pa
Frontiers in Pharmacology.2023;[Epub] CrossRef Detailed optical coherence tomography angiographic short‐term response of type 3 neovascularization to combined treatment with photodynamic therapy and intravitreal bevacizumab
Lisette M. Smid, Koenraad A. Vermeer, King T. Wong, José P. Martinez Ciriano, Jan H. de Jong, Valentina Davidoiu, Johannes F. de Boer, Mirjam E. J. van Velthoven
Acta Ophthalmologica.2021; 99(2): 207. CrossRef CHARACTERISTICS OF TYPE 3 NEOVASCULARIZATION LESIONS
Jae Hui Kim, Young Suk Chang, Jong Woo Kim, Chul Gu Kim, Dong Won Lee
Retina.2020; 40(6): 1124. CrossRef
|